Stan, a real patient currently taking VYNDAMAX (tafamidis) once daily

Hear from people and their loved ones living with ATTR-CM, transthyretin cardiac amyloidosis

Raymond’s storyAlan's story Stan's story

Meet Raymond

“ATTR-CM is a rare, progressive condition, and it's important to receive an accurate diagnosis as soon as possible. Learn more about it, and don't wait.”

- Raymond, a real patient with 
ATTR-CM taking VYNDAMAX

Meet Alan and Kathy

Create a discussion guide to talk to your doctor and start your own conversation about ATTR-CM

“I told my doctor how I was feeling and he told me it’s ATTR-CM. He told me there is no cure but VYNDAMAX slows it down and helps you live longer.”

- Alan, a real patient with ATTR-CM taking VYNDAMAX

“You have to advocate for yourself. Knowledge is power. You have to look into all the things you can do about ATTR-CM.”

-  Kathy, Alan’s partner and caregiver

Meet Stan

“My journey to diagnosis was fairly long…I had symptoms for at least 10 years before the final diagnosis was made.”

“I was glad to find out that there is treatment available…so that gave me some hope.”

“Once I learned that VYNDAMAX can help to slow the progression of ATTR-CM, I was eager to begin the treatment journey.”

- Stan, a real patient with ATTR-CM taking VYNDAMAX
Patient

Hear about Jack Nicklaus' ATTR‑CM Journey

Listen to Jack discuss ATTR-CM and VYNDAMAX.

Hear his story
Patient

Hear about Jack Nicklaus' ATTR‑CM Journey

Listen to Jack discuss ATTR-CM and VYNDAMAX.

Hear his story

Share your own ATTR-CM story